These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28771594)

  • 41. Skeletal muscle ultrastructure and function in statin-tolerant individuals.
    Rengo JL; Callahan DM; Savage PD; Ades PA; Toth MJ
    Muscle Nerve; 2016 Feb; 53(2):242-51. PubMed ID: 26059690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin use may reduce lower extremity peak force via reduced engagement in muscle-strengthening activities.
    Loenneke JP; Loprinzi PD
    Clin Physiol Funct Imaging; 2018 Jan; 38(1):151-154. PubMed ID: 27283255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statin Therapy as Primary Prevention in Exercising Adults: Best Evidence for Avoiding Myalgia.
    Bosomworth NJ
    J Am Board Fam Med; 2016 Nov; 29(6):727-740. PubMed ID: 28076256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skeletal muscle cell MHC I expression: implications for statin-induced myopathy.
    Singh P; Kohr D; Kaps M; Blaes F
    Muscle Nerve; 2010 Feb; 41(2):179-84. PubMed ID: 19813190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidative stress as a possible mechanism of statin-induced myopathy.
    Ahmadi Y; Ghorbanihaghjo A; Naghi-Zadeh M; Yagin NL
    Inflammopharmacology; 2018 Jun; 26(3):667-674. PubMed ID: 29574631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Annexin A1 is a biomarker of T-tubular repair in skeletal muscle of nonmyopathic patients undergoing statin therapy.
    Voigt T; Sebald HJ; Schoenauer R; Levano S; Girard T; Hoppeler HH; Babiychuk EB; Draeger A
    FASEB J; 2013 Jun; 27(6):2156-64. PubMed ID: 23413360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy.
    Stringer HA; Sohi GK; Maguire JA; Côté HC
    J Neurol Sci; 2013 Feb; 325(1-2):142-7. PubMed ID: 23312852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population.
    Caughey GE; Gabb GM; Ronson S; Ward M; Beukelman T; Hill CL; Limaye V
    JAMA Intern Med; 2018 Sep; 178(9):1224-1229. PubMed ID: 30073275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated skeletal muscle phosphodiesters in adults using statin medications.
    Slade JM; Delano MC; Meyer RA
    Muscle Nerve; 2006 Dec; 34(6):782-4. PubMed ID: 16881062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exercise-induced myalgia may limit the cardiovascular benefits of statins.
    Opie LH
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):569-72. PubMed ID: 23934075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rab-small GTPases are involved in fluvastatin and pravastatin-induced vacuolation in rat skeletal myofibers.
    Sakamoto K; Honda T; Yokoya S; Waguri S; Kimura J
    FASEB J; 2007 Dec; 21(14):4087-94. PubMed ID: 17634390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins and skeletal muscles toxicity: from clinical trials to everyday practice.
    Norata GD; Tibolla G; Catapano AL
    Pharmacol Res; 2014 Oct; 88():107-13. PubMed ID: 24835295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statin myotoxicity: a review of genetic susceptibility factors.
    Needham M; Mastaglia FL
    Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study.
    Ito MK; Maki KC; Brinton EA; Cohen JD; Jacobson TA
    J Clin Lipidol; 2014; 8(1):69-76. PubMed ID: 24528687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population.
    Hubacek JA; Adamkova V; Hruba P; Ceska R; Vrablik M
    Eur J Intern Med; 2015 Jun; 26(5):367-8. PubMed ID: 25753936
    [No Abstract]   [Full Text] [Related]  

  • 56. Inflammatory myopathy associated with statins: report of three cases.
    Kuncova K; Sedlackova M; Vencovsky J; Mann H; Tomcik M; Wenchich L; Zamecnik J
    Mod Rheumatol; 2014 Mar; 24(2):366-71. PubMed ID: 24593216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An update on the relationship between statins and physical activity.
    Panza GA; Taylor BA; Thompson PD
    Curr Opin Cardiol; 2016 Sep; 31(5):572-9. PubMed ID: 27428007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does Coenzyme Q10 Supplementation Mitigate Statin-Associated Muscle Symptoms? Pharmacological and Methodological Considerations.
    Taylor BA
    Am J Cardiovasc Drugs; 2018 Apr; 18(2):75-82. PubMed ID: 29027135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular clues into the pathogenesis of statin-mediated muscle toxicity.
    Baker SK
    Muscle Nerve; 2005 May; 31(5):572-80. PubMed ID: 15712281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are Chronic Pain Syndromes the Reason for Statin-associated Muscle Symptoms?
    Sheinin R; Nogueira AR; Bragazzi NL; Watad A; Tiosano S; Gonen T; Sharif K; Kameri Y; Amital H; Amital D; Cohen H
    Isr Med Assoc J; 2022 Nov; 24(11):719-726. PubMed ID: 36436038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.